Search

Search Results

• 

  Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement

  Sara Ferrigno, Immacolata Prevete, Valeria Orefice, Chiara Scirocco, Gian Domenico Sebastiani

  08-04-2026

  https://doi.org/10.4081/reumatismo.2026.1956

  448

  PDF: 64

• PO:15:209 | Attainment of remission or lupus low disease activity state in single center Lupus Clinic Paola Tedoldi^1|2, Silvia Ebe Lucia Della Pina^1|2, Claudia Barison^1|2, Chiara Orlandi^1|2, Cecilia Nalli¹, Micaela Fredi², Ilaria Cavazzana^1|2, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology Unit- ERN ReCONNET, ASST Spedali Civili of Brescia Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2325

  48

• CO:11:3 | Belimumab for lupus nephritis patients with poor kidney function: a post-hoc analysis of the bliss-ln trial Giacomo Emmi^1|2, Ersilia Lucenteforte³, Giorgio Limoncella³, Emanuele Chiara^1|2, Marta Calatroni^4|5, Gabriella Moroni^4|5 | ¹Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; ²Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; ³Department of Statistics, Informatics and Applications Giuseppe Parenti, University of Florence, Florence, Italy; ⁴Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; ⁵Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2278

  22

• CO:11:6 | Off-therapy remission in systemic lupus erythematosus: the BLys lupus flare index (BLyFI) as a decision tool for immunosuppressive therapy withdrawal in remitted patients Noemi Merra¹, Anna Giorgia Osele¹, Davide Ragno¹, Greta Hulej¹, Zahrà Rahmé¹, Ilenia Anna Gennaio¹, Filippo Vesentini¹, Margherita Zen¹, Luca Iaccarino¹, Andrea Doria¹ | Università degli Studi di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2121

  167
• 

  The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

  Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

  23-07-2025

  https://doi.org/10.4081/reumatismo.2025.1830

  1748

  PDF: 187

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  https://doi.org/10.4081/reumatismo.2005.109

  1158

  PDF: 3919

• PO:16:236 | Achieving a low disease activity state with a corticosteroid dose of 5 mg or less: observational study with anifrolumab in patients with systemic lupus erythematosus in Italy Alessandra Bortoluzzi¹, Fulvia Ceccarelli², Fabio Leo³, Paola Roccatagliata³, Chiara Tani⁴, Margherita Zen⁵ | ¹Azienda Ospedaliera Universitaria Sant' Anna di Cona, Università di Ferrara Italy; ²Unità di Reumatologia, Università Sapienza Roma Italy; ³AstraZeneca S.p.a. Milano Italy; ⁴Università di Pisa e Azienda Ospedaliero Universitaria Pisana, Pisa Italy; ⁵Dipartimento di Medicina DIMED , Divisione di Reumatologia, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2163

  128
• 

  IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome

  A. Alunno, O. Bistoni, E. Bartoloni Bocci, S. Caterbi, B. Bigerna, A. Pucciarini, A. Tabarrini, R. Mannucci, D. Beghelli, B. Falini, R. Gerli

  192-198

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.192

  3965

  PDF: 1066

• PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini¹, Luca Iaccarino¹, Federico Arru², Greta Hulej¹, Anna Giorgia Osele¹, Noemi Merra¹, Davide Ragno¹, Andrea Doria¹, Margherita Zen¹ | ¹UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; ²UO Medicina, ASL 3 Nuoro, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2162

  142

• PO:17:254 | Systemic lupus erythematosus with pulmonary involvement: clinical insights from an Albanian cohort Arbi Pecani¹, Arian Mezini², Loreta Karaulli², Laert Gjati², Silvana Bala² | ¹Reumatologia, Dipartimento di Medicina Interna, Università di Medicina di Tirana, Ospedale Universitario Shefqet Ndroqi, Tirana; ²Pneumologia, Dipartimento di Medicina Respiratoria, Ospedale Universitario Shefqet Ndroqi, Tirana, Albania

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2168

  168
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  125-135

  28-06-2014

  https://doi.org/10.4081/reumatismo.2014.785

  8883

  PDF: 3701

• PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2043

  142

• Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies

  M. Frassi, A. Brucato, I. Cavazzana, F. Franceschini, D. Faden, M. Motta, A. Doria, R. Cimaz, M.P. Pisoni, M. Muscarà, G. Castellino, G. Brambilla, P.L. Meroni, R. Cattaneo, C. Biasini Rebaioli, C. Antonioli, G. Balestrieri, A. Tincani

  298-304

  https://doi.org/10.4081/reumatismo.2001.298

  1706

  PDF: 1187

• CO:11:4 | Unveiling frailty in active systemic lupus erythematosus  in the modern era of rheumatology: first real-life use of the SLICC-FI  in a cohort diagnosed after 2000 Angela Elia¹, Dina Zucchi², Michele Moretti¹, Elena Elefante², Chiara Cardelli¹, Linda Carli², Viola Signorini², Chiara Stagnaro², Chiara Tani¹, Marta Mosca¹. | ¹U.O. di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa; ²U.O Reumatologia, Azienza Ospedaliero Universitaria Pisana, Pisa, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1996

  178

• PO:14:196 | Photosensitivity in Lupus Erythematosus: The Patients' Perspective in a National Survey Marianna Salis¹, Elisabetta Chessa², Alessandra Oliva¹, Marta Paola Pireddu¹, Fabio Congiu¹, Giulia Rizzo¹, Elena Ragusa¹, Alberto Cauli^1|2, Laurent Arnaud³, Matteo Piga^1|2 | ¹Università degli Studi di Cagliari, Italy; ²Azienda Ospedaliera Universitaria di Cagliari, Unità Operativa Complessa di Reumatologia Cagliari, Italy; ³Strasbourg University and Academic Hospitals Strasbourg, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2320

  25

• PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study Giuseppe Alvise Ramirez^1|2, Gabriele D Gallina¹, Chiara Calabrese^1|2, Serena Nannipieri^1|2, Marta Calatroni^3|4, Francesco Reggiani^3|4, Giovanni Benanti¹, Enrica Paola Bozzolo¹, Raffaele Ceniccola², Luca Moroni^1|2, Marco Matucci-Cerinic^1|2, Gabriella Moroni^3|4, Lorenzo Dagna^1|2 | ¹IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases Milan, Italy; ²Vita- Salute San Raffaele University Milan, Italy; ³IRCCS Humanitas Research Hospital, Nephrology and Dialysis Division Rozzano, Milan, Italy; ⁴Humanitas University, Department of Biomedical Sciences Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2334

  46

• PO:15:212 | Anifrolumab induces a rapid improvement in joint inflammation in Systemic Lupus Erythematosus patients: an ultrasonographic study Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Valerio Fiorilli, Francesca Romana Spinelli, Fabrizio Conti | Sapienza Università di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2326

  21

• CO:10:6 | Impact of pregnancy on organ damage in systemic lupus erythematosus: a prospective multicenter study Giancarlo Cascarano¹, Greta Hulej², Dina Zucchi¹, Antonia Calligaro², Elena Elefante¹, Luca Iaccarino², Sabrina Gori¹, Margherita Zen², Chiara Tani¹, Andrea Doria², Marta Mosca¹. | ¹Università degli Studi di Pisa; ²Università degli Studi di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1995

  154

• Neuropsychiatric Lupus Erythematosus

  M. Vadacca, F. Buzzulini, A. Rigon, G. Coppolino, A. Palma Modoni, R. Massa, A. Afeltra

  177-186

  https://doi.org/10.4081/reumatismo.2006.177

  4078

  PDF: 17436

• PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi¹, Maria Chiara Gerardi¹, Bianca Lucia Palermo¹, Giulia Carrea¹, Maria Di Cicco¹, Elena Manna¹, Giulia Segatto¹, Antonella Adinolfi¹, Laura Belloli¹, Cinzia Casu¹, Silvia Cavalli¹, Davide Antonio Filippini¹, Matteo Longhi¹, Gabriella Maioli¹, Martina Schettino¹, Nicola Ughi¹, Elisa Verduci¹, Arianna Bertolucci¹, Lara Buffa¹, Giulia Buonsante¹, Claudia Cordini¹, Eleonora Giacobbe¹, Francesco Molica Colella¹, Oscar Epis¹ | ¹ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2165

  165
• 

  Systemic lupus erythematosus and infections

  B.K. Singh, S. Singh

  154-169

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1303

  5159

  PDF: 2981

• PO:16:241 | Prevalence and associated factors of premature ovarian insufficiency in women with systemic lupus erythematosus: the role of human herpesviruses HHV-7 and HHV-8 Margherita Rizzo¹, Francesca Ruffilli¹, Silvia Beltrami², Daria Bortolotti², Roberta Rizzo², Carlo Garaffoni¹, Ettore Silvagni¹, Marcello Govoni¹, Alessandra Bortoluzzi¹ | ¹UOC Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara e Azienda Ospedaliero-Universitaria S. Anna, Ferrara; ²Dipartimento di Scienze Chimiche, Farmaceutiche e Agrarie, Ferrara Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2164

  161

• PO:16:226 | Clinical Phenotypes of Systemic Lupus Erythematosus: An Exploratory Cluster Analysis in a Monocentric Cohort Richard Borrelli¹, Stefania Nicola¹, Federica Corradi¹, Iuliana Badiu¹, Luca Lo Sardo¹, Marzia Boem¹, Valentina Marmora¹, Simone Negrini¹, Luisa Brussino¹ | ¹SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2332

  24

• PO:15:219 | Nailfold capillaroscopic abnormalities in systemic lupus erythematosus: comparison with healthy controls and clinical-immunological correlations. Preliminary data Chiara Orlandi^1|2, Alessia Loda², Cesare Tomasi^1|2, Silvia Ebe Lucia Della Pina^1|2, Claudia Barison^1|2, Cecilia Nalli¹, Ilaria Cavazzana^1|2, Micaela Fredi^1|2, Franco Franceschini^1|2. | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET , ASST Spedali Civili of Brescia, Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2039

  137
• 

  Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study

  A. Fayed, M.M. El Menyawi, M. Ghanema, O. Shaker, R. Elgohary

  145-153

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1308

  1342

  PDF: 770

• PO:10:155 | Etanercept-induced lupus in a patient with rheumatoid arthritis: diagnostic challenges and multidisciplinary therapeutic approach Camilla Riboldi^1|2, Claudia Iannone^1|2, Maria Gerosa^1|2, Roberto Felice Caporali^1|2 | ¹ASST G. Pini-CTO, U.O.C. di Clinica Reumatologica, Milano; ²Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2149

  148
• 

  Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis

  L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca

  203-204

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.203

  2733

  PDF: 770

  Appendix: 358

• PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case Angela Carenza¹, Liliana Dinoia², Sergio De Gioia², Federica Gatti¹, Teresa Caferri¹, Lucia Cristiana Colaprico¹, Angelica Napoletano¹, Giuseppe Lopalco¹, Florenzo Iannone¹. | ¹Rheumatology Unit, University of Bari, Department of Precision and Regenerative Medicine, Jonian area ^DiMePRe-J, Bari, Italy; ²Azienda Sanitaria Locale di Taranto, presidio ospedaliero SS. Annunziata, Unità Operativa di Reumatologia, Taranto, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2047

  174

• PO:15:224 | Measuring disease activity in Systemic Lupus Erythematosus patients: SLE-DAS usefulness in real-life setting Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Cristina Garufi, Alessandra Ida Celia, Silvia Mancuso, Angelica Gattamelata, Simona Truglia, Francesca Romana Spinelli, Cristiano Alessandri, Fabrizio Conti | La sapienza Università di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2330

  18

• Role of anti-prothrombin in antiphospholipid syndrome

  M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

  243-250

  https://doi.org/10.4081/reumatismo.2002.243

  940

  PDF: 1392

• PO:15:220 | Outcomes of extra renal flares in systemic lupus erythematosus: longitudinal analysis of a monocentric cohort Marco Oliva¹, Giorgia Capozzo¹, Giancarlo Cascarano¹, Chiara Cardelli¹, Dina Zucchi¹, Angela Elia¹, Elena Elefante², Viola Signorini², Chiara Stagnaro², Chiara Tani¹, Marta Mosca¹. | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; ²Rheumatology Unit, AOUP, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2040

  149

• CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo¹, Fabio Congiu¹, Elisabetta Chessa², Marta Paola Pireddu¹, Elena Ragusa¹, Alessandra Oliva¹, Marianna Salis¹, Alberto Cauli^1|2, Matteo Piga^1|2 | ¹SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; ²SC Reumatologia, AOU Cagliari Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2120

  230
• 

  Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients

  I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1541

  1418

  PDF: 738

• Ro60 and La ribonucleoproteins become self-aggregated by cell stress

  S.H. Sánchez-Rodríguez, D. Herrera-van-Oostdam, E. Avalos-Díaz, R. Herrera-Esparza

  292-298

  https://doi.org/10.4081/reumatismo.2007.292

  1029

  PDF: 918

• PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence Giulia Cassone², Filippo Santoro¹, Caterina Vacchi², Dilia Giuggioli², Chiara Cabassi¹ | ¹UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; ²UOC Reumatologia, AOU Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2337

  77

• PO:18:277 | Clinical case report of the management of a patient suffering from systemic lupus erythematosus and associated polyneuropathy Davide Murgia¹, Elena Marazzi¹, Rosetta Vitetta¹, Guido Rovera¹. | ¹ASLVC SSD reumatologia, Ospedale sant'Andrea Vercelli, Vercelli, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2048

  157

• PO:15:216 | Safety and Efficacy of a single dose of Rituximab to manage Pregnancy-Related Severe Flare of Systemic Lupus Erythematosus: A Case Report Eugenio Capparelli¹, Daniela Bompane¹, Eleonora Zaccara¹, Laura Castelnovo¹, Antonio Tamburello¹, Antonino Mazzone², Paola Faggioli¹ | ¹UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; ²UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2329

  34

• CO:01:3 | Which PRO reflects remission best? Bridging the gap between patient and physician in systemic lupus erythematosus Elena Ragusa¹, Elisabetta Chessa², Marta Paola Pireddu¹, Fabio Congiu¹, Giulia Rizzo¹, Marianna Salis¹, Alessandra Oliva¹, Mattia Congia², Alberto Cauli^1|2, Matteo Piga^1|2. | ¹SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; ²SC Reumatologia, AOU Cagliari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1963

  221
• 

  Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report

  L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1597

  1384

  PDF: 942

• PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi¹, Chiara Cocco¹, Ramona Santangeli¹, Lucia Gamba¹, Paola Fioretti¹, Letizia Curina¹, Chiara Guidoni¹, Edoardo Cipolletta³, Gianluca Moroncini² | ¹Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; ²Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; ³Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2336

  59

• Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

  D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1658

  1205

  PDF: 411

• PO:15:215 | Evaluating the Prognostic Value of Modified NIH Indices and Total Renal Chronicity Score in Lupus Nephritis: a single center retrospective analysis Alessandra Ida Celia¹, Andrea Ascione², Bruna Cerebelli², Martina Leopizzi², Cristiano Alessandri¹, Francesca Romana Spinelli¹, Fabrizio Conti¹ | ¹Reumaologia, Scienze Cliniche internistiche, anestesiologiche e cardiovascolari, Università La Sapienza di Roma, Italy; ²Anatomia patologica, Dipartimento di Scienze biotecnologiche medico-chirurgiche, Università La Sapienza di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2328

  17

• CO:05:1 | Predicting one-year disease activity in systemic lupus erythematosus using machine learning and explainable AI Pier Giacomo Cerasuolo¹, Augusta Ortolan¹, Livia Lilli², Laura Antenucci², Carlotta Maschiocchi², Jacopo Lenkowicz², Lucia Lanzo¹, Luca Petricca¹, Maria Rita Gigante¹, Vivianaantonella Pacucci¹, Pierluigi Rizzuti¹, Rebecca Ventura¹, Silvia Piunno¹, Cesare Gavotti¹, Marco Gorini³, Gabriella Castellino³, Alfredo Cesario², Stefano Patarnello², Silvia Laura Bosello¹, Maria Antonietta D'Agostino¹. | ¹UOC di Reumatologia ed Immunologia Clinica, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma; ²Gemelli Generator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma; ³AstraZeneca Italy, MIND, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1970

  208

• PO:14:193 | Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 Trial Megan EB Clowse¹, Marta Mosca², David A Isenberg³, Joan T Merrill⁴, Thomas Dörner⁵, Michelle Petri⁶, Edward M Vital^7|8, Eric F Morand⁹, Teri Jimenez¹⁰, Stephen Brookes¹¹, Janine Gaiha-Rohrbach¹², Christophe Martin¹³, Annette Nelde¹⁴, Christian Stach¹⁵ | ¹Duke University - Division of Rheumatology and Immunology Durham, USA; ²University of Pisa - Rheumatology Unit, Department of Clinical and Experimental Medicine Pisa, Italy; ³University College London - Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine London, United Kingdom; ⁴Oklahoma Medical Research Foundation Oklahoma City, USA; ⁵Charité Universitätsmedizin Berlin - Department of Medicine/Rheumatology and Clinical Immunology Berlin Germany; ⁶Johns Hopkins University School of Medicine Baltimore, USA; ⁷University of Leeds - Leeds Institute of Rheumatic and Musculoskeletal Medicine Leeds, United Kingdom; ⁸Leeds Teaching Hospitals NHS Trust - NIHR Leeds Biomedical Research Centre Leeds, United Kingdom; ⁹Monash University - Centre for Inflammatory Diseases Melbourne, Australia; ¹⁰UCB Raleigh, USA; ¹¹Biogen Maidenhead, United Kingdom; ¹²Biogen Cambridge, USA; ¹³UCB Slough, United Kingdom; ¹⁴Biogen Baar, Switzerland; ¹⁵UCB Monheim am Rhein, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2318

  51
• 

  Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage

  P. Sukhadiya, P. Kumar, D.S. Meena, A. Kumar P.H., N. Vijayan, P. Garg, M.K. Garg

  21-03-2023

  https://doi.org/10.4081/reumatismo.2022.1488

  1868

  PDF: 807

• PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort Fabio Congiu¹, Elisabetta Chessa², Giulia Rizzo¹, Elena Ragusa¹, Marta Paola Pireddu¹, Alessandra Oliva¹, Marianna Salis¹, Mattia Congia², Maria Maddalena Angioni¹, Micaela Rita Naitza¹, Alberto Floris², Alberto Cauli^1|2, Matteo Piga^1|2 | ¹AOU e Università degli studi di Cagliari; ²SC Reumatologia PO Duilio Casula, Cagliari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2167

  166

• PO:16:240 | Systemic Lupus Erythematosus Presenting as End-Stage Liver Disease: A Case Report and Literature Review Annamaria Tiso¹, Stefania Caccavelli¹, Giuseppina Caroppi¹, Candida Tarullo¹, Gaetano Serviddio¹ | ¹Policlinico Riuniti Foggia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2335

  50

• Neuropsychiatric systemic lupus erythematosus: where are we now?

  M. Govoni, N. Rizzo, G. Castellino, M. Padovan, F. Trotta

  215-225

  https://doi.org/10.4081/reumatismo.2005.215

  1394

  PDF: 3272

• PO:15:214 | Identification of SLE patients with high-levels Type 2 SLE through the polysymptomatic distress scale (PSD): correlations with other PROs and differences in clinical phenotypes in a multicentric cohort Micaela Fredi^1|2, Giorgia Gozzoli^1|2, Federica Bonaso^1|2, Silvia Ebe Della Pina^1|2, Claudia Barison^1|2, Irene Lorenzini², Anna Mattiuzzo², Raffaele Pericotti², Marcelo Neto³, Sofia Avedo⁴, Clàudia Oliveira⁴, Luis Sousa Ines³, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center, Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; ³Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; ⁴Rheumatology Department, ULS Aveiro, Aveiro, Portugal

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2327

  19

• PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi¹, Sheryl A. Kluberg², Sophie E. Mayer², O'Mareen Spence³, Driss Oraichi³, Harry Seifert³, Omar Ali³, Huifeng Yun³, Andrew L. Simon⁴, Jenice S. Ko⁴, Caroline Hugh⁴, Meg Her⁴, Kathleen Shattuck⁴, Richard Platt², Aziza Jamal-Allial⁵, Djeneba Audrey Djibo⁶, Kimberly Daniels⁵, Qianli Ma⁷, Cheryl N. Mcmahill-Walraven⁶, Rachel P. Ogilvie⁸, Kristin Palmsten⁹, Mano Selvan⁷, Najat Ziyadeh⁸, Alexis Ogdie¹⁰, Michael George¹⁰ | ¹GSK Verona Italy; ²Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ³GSK Rockville; ⁴Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ⁵Carelon Research, Wilmington; ⁶CVS Health, Blue Bell; ⁷Humana Healthcare Research, Louisville; ⁸OptumInsight Life Sciences, Boston; ⁹HealthPartners Institute, Bloomington; ¹⁰University of Pennsylvania, Philadelphia, USA

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2166

  146